Price is syncing
Reported smart-money activity is still available below.
1 month
+2.3%
price return
Year to date
-4.5%
price return
Recent earnings
3/4
quarters beat
News tone
Bullish
20 articles, 7 days
Filed positions and reported activity tied to this stock.
Real smart money
Insiders
Influencers
Recent coverage and its overall tone.
News
Coverage is bullish
14 bullish · 6 neutral · 0 bearish
Tone of tracked coverage
Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX), UnitedHealth (UNH) and AnaptysBio (ANAB)
Leans bullishJul 22Protagonist Therapeutics stock hits all-time high at 141.79 USD By Investing.com
BullishJul 20Protagonist Therapeutics stock hits all-time high at 141.79 USD By Investing.com
BullishJul 20Protagonist Therapeutics (PTGX) Rises In Biotech Rally While Valuation Keeps The Debate Open
Leans bullishJul 20Protagonist Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
NeutralJul 20Protagonist Therapeutics (PTGX) Barclays 28th Annual Global Healthcare Conference summary
BullishJul 20Protagonist Therapeutics stock hits all-time high at 141.79 USD
BullishJul 20Protagonist Therapeutics (PTGX) Rises In Biotech Rally While Valuation Keeps The Debate Open
NeutralJul 19